Ichthyosis prematurity syndrome is a rare autosomal recessive genodermatosis that is associated with mutations in the SLC27A4 gene. Its onset occurs in early childhood and presents with the clinical triad of premature birth, thick caseous desquamating epidermis, and neonatal asphyxia. Here, we describe a prematurely born baby patient (33 weeks of gestation) with a homozygous variant at the initiation codon site (c.1 A> G, p.Met1Val) in the SLC27A4 gene to raise awareness of this rare syndrome despite its distinctive features as we believe it is still underdiagnosed.

Ichthyosis prematurity syndrome (IPS, OMIM608649) is a rare autosomal recessive disorder characterized by the clinical triad of premature birth, ichthyosis, and neonatal asphyxia [1]. It is caused by a mutation in SLC27A4 (solute carrier family 27 member 4, which encodes fatty acid transport protein 4 [FATP4]) [2]. Here, we describe an IPS patient with a homozygous pathogenic variant at the initiation codon site (c.1 A> G, p. Met1Val) in the SLC27A4 gene to raise awareness of this rare syndrome despite its distinctive features as we believe it is still underdiagnosed.

A 33-week gestation baby boy was born to a healthy consanguineous parent by caesarian section due to premature rupture of the membrane and chorioamnionitis. At birth, he weighed 2.7 kg (10th centile) and 47.5 cm in length (10th centile), and his head circumference was 34 cm (10th centile). His Apgar scores were 7 and 8 at the 1st and 5th min, and he was admitted to the Neonatal Intensive Care Unit due to respiratory distress and was intubated on continuous positive pressure mechanical ventilation. At 32 weeks of gestation, antenatal course of dexamethasone was given to promote lung maturity.

On examination, the baby had no dysmorphic features. His skin examination revealed generalized thick verruciform hyperkeratotic plaques with cobblestone appearance covering all of his body including the scalp with focal areas of hair loss (Fig. 1). Mucous membranes and nails were normal. Ophthalmology examination was normal. His blood eosinophilia at birth was 1,700 cell/mm3, peaked at day 7 reaching 2,300 cell/mm3 and normalized at the age of 1 month. The clinical diagnosis of IPS was rendered and later proven by whole-exome sequencing revealing that he was carrying a homozygous pathogenic variant (c.1A > G, p. Met1Val) in the SLC27A4 gene with parents heterozygous for the same variant.

Fig. 1.

Photograph of the patient at birth shows a multiple thick verruciform hyperkeratotic plaques with cobblestone appearance covering all of his body including the scalp and b cobblestone plaques covering the face, more prominent over the forehead.

Fig. 1.

Photograph of the patient at birth shows a multiple thick verruciform hyperkeratotic plaques with cobblestone appearance covering all of his body including the scalp and b cobblestone plaques covering the face, more prominent over the forehead.

Close modal

The proband was managed by using an incubator with 80% humidity and intravenous hydrocortisone at a dose of 1 mg/kg/dose 6 h for 7 days. Skin was managed conservatively by applying frequent, generous amount of petroleum jelly. Over the next 4 weeks, ichthyosis resolved gradually and completely (Fig. 2). The patient developed recurrent pneumonia with recurrent admission to the hospital and was treated with intravenous antibiotics.

Fig. 2.

Photograph of the patient at the age of 1 month showing resolution of ichthyosis.

Fig. 2.

Photograph of the patient at the age of 1 month showing resolution of ichthyosis.

Close modal

IPS is a rare autosomal recessive disorder, first recognized in 1993 [3]. Leaute-Labreze et al. [4] suggested the term “Self-Healing Congenital Verruciform Hyperkeratosis,” because skin findings improve spontaneously unlike other forms of congenital ichthyosis, although some patients may persist with skin xerosis or atopy [5]. Neonatal asphyxia is thought to be due to aspiration of skin debris that shed into amniotic fluid [5]. Antenatal ultrasound may show separation of chorionic and amniotic membranes and polyhydramnios with starry sky appearance [4, 5]. Histopathology of skin is pathognomonic with acanthosis, hyperkeratosis, and characteristic aggregates of curved lamellar structures in the perinuclear cytosol of the stratum corneum and stratum granulosum [6]. Perivascular inflammation with eosinophilia was seen in some cases [6].

On electron microscopy, some authors described it as worm-like structures in corneocytes [4]. Transient blood eosinophilia like in our patient has been noticed occasionally [1].

Respiratory complications are the leading cause of death due to inhalation of debris [1]. Considering that lung pathology might be due to aspiring skin debris, we believe that systemic steroids might help mitigating the respiratory complications [7].

IPS was previously reported due to mutation within SLC27A4 that encodes FATP4 [2]. The described c.1A > G, p. Met1Val variant in our patient was previously reported in dbSNP (rs746178942) and in the gnomAD database, resulting in loss of the initiation codon leading to pathological effect on FATP4 protein [8]. The FATP families are transmembrane proteins that transport exogenous fatty acids into cells and activate them. They also function as acyl-CoA synthetases with specificity for very long-chain fatty acids (VLCFA), reducing VLCFA-CoA synthetase activity and incorporation of VLCFA into neutral and polar lipids [2].

Animal studies suggest that multiple FATPs specifically FATP4 are important for skin barrier function, particularly during embryonic and neonatal period, but are not vital postnatally as other FTAPs may compensate [9]. This may explain spontaneous skin improvement soon after birth [2].

We are presenting and emphasizing the pathognomonic and special cobblestone appearance of ichthyosis in IPS. We also think that systemic steroids may improve the prognosis.

We are grateful to Ms. Zoe Poral Camarig for her secretarial support in proofreading and editing the manuscript.

Written informed consent was obtained from the parent/legal guardian of the patient for publication of the details of this medical case and any accompanying images. The case complied with the Declaration of Helsinki. This case is a part of a study approved by the International Review Board (IRB), Ministry of National Guard – Health Affairs (Protocol # RC20/108/R).

The authors have no conflicts of interest to declare.

There was no funding, and the authors have no conflicts either actual or perceived.

Sultan Al-Khenaizan and Asma AlSwailem were involved in contact with the patient, photography, obtaining written consent, and diagnosis of the patient. Mohammed Ali AlBalwi contributed to molecular genetic diagnosis and is the supervisor of the study. All authors contributed to literature review, manuscript writing, and manuscript reviewing.

All patient data are available in this manuscript.

1.
Bygum
A
,
Westermark
P
,
Brandrup
F
.
Ichthyosis prematurity syndrome: a well-defined congenital ichthyosis subtype
.
J Am Acad Dermatol
.
2008
;
59
:
S71
4
.
2.
Klar
J
,
Schweiger
M
,
Zimmerman
R
,
Zechner
R
,
Li
H
,
Törmä
H
,
Mutations in the fatty acid transport protein 4 gene cause the ichthyosis prematurity syndrome
.
Am J Hum Genet
.
2009 Aug
;
85
(
2
):
248
53
.
3.
Niemi
KM
,
Kuokkanen
K
,
Kanerva
L
,
Ignatius
J
.
Recessive ichthyosis congenita type IV
.
Am J Dermatopathol
.
1993
;
15
:
224
8
.
4.
Léauté-Labrèze
C
,
Boralevi
F
,
Cony
M
,
Maleville
J
,
Lacombe
D
,
Surlève-Bazeille
JE
,
Self-healing congenital verruciform hyperkeratosis
.
Am J Med Genet A
.
2004 Oct 15
;
130A
(
3
):
303
6
.
5.
Dereksson
K
,
Kjartansson
S
,
Hjartardóttir
H
,
Arngrimsson
R
.
Ichthyosis prematurity syndrome with separation of fetal membranes and neonatal asphyxia
.
BMJ Case Rep
.
2012 Aug 27
;
2012
:
bcr0220125823
.
6.
Khnykin
D
,
Rønnevig
J
,
Johnsson
M
,
Sitek
JC
,
Blaas
HG
,
Hausser
I
,
Ichthyosis prematurity syndrome: clinical evaluation of 17 families with a rare disorder of lipid metabolism
.
J Am Acad Dermatol
.
2012 Apr
;
66
(
4
):
606
16
. . Epub 2011 Aug 19.
7.
Roberts
D
,
Brown
J
,
Medley
N
,
Dalziel
SR
.
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
.
Cochrane Database Syst Rev
.
2017
;
3
:
CD004454
.
8.
Inhoff
O
,
Hausser
I
,
Schneider
SW
,
Khnykin
D
,
Jahnsen
FL
,
Sartoris
J
,
Ichthyosis prematurity syndrome caused by a novel fatty acid transport protein 4 gene mutation in a German infant
.
Arch Dermatol
.
2011 Jun
;
147
(
6
):
750
2
.
9.
Schmuth
M
,
Ortegon
AM
,
Mao-Qiang
M
,
Elias
PM
,
Feingold
KR
,
Stahl
A
.
Differential expression of fatty acid transport proteins in epidermis and skin appendages
.
J Invest Dermatol
.
2005 Dec
;
125
(
6
):
1174
81
.
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.